Moneycontrol
HomeNewsBusinessExplained | What is Inland Vessels Bill 2021 and how does it benefit the country?
Trending Topics

Explained | What is Inland Vessels Bill 2021 and how does it benefit the country?

The government expects the new law to remove bottlenecks for vessel movement within the country but experts say that while this would benefit MSMEs, Indian waterways need to be developed further and made navigable throughout the year for proper industrial use

July 30, 2021 / 17:46 IST
Story continues below Advertisement
Source: Reuters

The Inland Vessels Bill, 2021 that was passed by Lok Sabha on July 21, will help domestic cargo movement with potentially lower rates, which is expected to help small businesses.

The proposed law is in line with the Narendra Modi government’s aim to develop inland ports and harness India’s 7,500km coastline and potentially navigable waterways.

Story continues below Advertisement

The government expects its programme to create 1 crore new jobs, including direct employment of 40 lakh people, in the next 10 years, reduce logistics costs and speed up cargo movement.

The new law will replace the century-old Inland Vessels Act of 1917 for the regulation of security, safety as well as registration of inland vessels.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show